- In December 2023, Roche entered into a definitive agreement to acquire LumiraDx's Point of Care technology. This acquisition involves a platform that integrates multiple diagnostic modalities on a single instrument, enabling faster, more affordable, and accessible testing in decentralized healthcare settings. The technology will enhance Roche’s existing diagnostics portfolio, spanning across immunoassay, clinical chemistry, and molecular tests. By incorporating LumiraDx's innovations, Roche aims to improve patient access to timely and accurate diagnostics in various settings, such as home care, pharmacies, and general practices. This acquisition is expected to expand Roche’s point-of-care solutions and drive market growth in decentralized diagnostics
- In July 2022, Thermo Fisher Scientific showcased new clinical and research lab solutions at AACC 2022. The company introduced innovative platforms and technologies designed to improve diagnostic development and laboratory productivity. These solutions, including advanced testing kits and automation systems, aim to minimize hands-on time and accelerate time-to-results, enhancing efficiency in clinical diagnostics. The impact on the market includes a significant boost in the adoption of rapid, high-precision diagnostics, particularly in infectious diseases and autoimmune testing. This development positions Thermo Fisher as a leader in the evolving diagnostics sector, supporting improved patient outcomes globally
- In May 2022, Hologic received the European CE mark for two new molecular assays—the Panther Fusion EBV Quant Assay and Panther Fusion BKV Quant Assay—designed for transplant patients. These assays quantify the viral load of Epstein-Barr virus and BK virus in whole blood, plasma, and urine samples. By aiding in the diagnosis and management of solid organ and stem cell transplant patients, these assays provide critical tools for monitoring infections in immunocompromised individuals. The new assays will enhance diagnostic capabilities on the Panther Fusion system, improving patient outcomes and driving market growth in transplant diagnostics
